Apr 20, 2022 / 12:00PM GMT
Operator
Good afternoon, ladies and gentlemen and welcome to the Oxford Biomedica Preliminary Results 2021 Conference Call. (Operator Instructions) As a reminder, today's conference call is being recorded.
Sophia Bolhassan - Oxford Biomedica plc - Head of IR
Welcome, everybody, and thank you for joining us for our preliminary results 2021 conference call. I'm Sophia Bolhassan, Head of Investor Relations, and I'm joined here today by Roch Doliveux, Chairman and Interim Chief Executive Officer; Stuart Paynter, Chief Financial Officer; and Kyri Mitrophanous, Chief Scientific Officer.
I'll now hand over to Roch to begin the presentation.
Roch Doliveux - Oxford Biomedica plc - Interim CEO & Chairman
Thank you very much, Sophia. And welcome everybody to the 2021 financial results for Oxford Biomedica. I will share with you a couple of slides on where is the company and then let Stuart highlight the financial results and Kyri and Stuart talk about the future.
First of all, I'm clearly delighted about the 2021
Full Year 2021 Oxford BioMedica PLC Earnings Call Transcript
Apr 20, 2022
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers